Clinical Trial Update: Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating sorafenib in combination with cyclophosphamide/topotecan for relapsed and refractory neuroblastoma; the study status is ACTIVE_NOT_RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Sorafenib (Sorafenib)
• Topotecan (topotecan)

Snippet

Sponsor: New Approaches to Neuroblastoma Therapy Consortium | Conditions: Neuroblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING